These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18661518)

  • 1. Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer.
    Skírnisdóttir I; Garmo H; Wilander E; Holmberg L
    Int J Cancer; 2008 Oct; 123(8):1897-901. PubMed ID: 18661518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival in women with borderline ovarian tumors: a population-based survey of borderline ovarian tumors in Sweden 1960-2007.
    Kalapotharakos G; Högberg T; Bergfeldt K; Borgfeldt C
    Acta Obstet Gynecol Scand; 2016 Apr; 95(4):473-9. PubMed ID: 26714557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
    Jordan SJ; Green AC; Whiteman DC; Webb PM;
    Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer.
    Skírnisdóttir I; Garmo H; Holmberg L
    Gynecol Oncol; 2007 Apr; 105(1):166-71. PubMed ID: 17184826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histology-specific long-term trends in the incidence of ovarian cancer and borderline tumor in Japanese females: a population-based study from 1983 to 2007 in Niigata.
    Yahata T; Banzai C; Tanaka K;
    J Obstet Gynaecol Res; 2012 Apr; 38(4):645-50. PubMed ID: 22381138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.
    Hannibal CG; Huusom LD; Kjaerbye-Thygesen A; Tabor A; Kjaer SK
    Acta Obstet Gynecol Scand; 2011 Apr; 90(4):305-12. PubMed ID: 21306323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of second cancer among patients with ovarian borderline tumors.
    Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
    Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declining trends of epithelial ovarian cancer in California.
    Morris CR; Rodriguez AO; Epstein J; Cress RD
    Gynecol Oncol; 2008 Jan; 108(1):207-13. PubMed ID: 18028989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borderline ovarian tumors in Denmark 1997-2018: Time trends in incidence by histology, age and educational level.
    Baandrup L; Faber MT; Aalborg GL; Kjaer SK
    Acta Obstet Gynecol Scand; 2021 Mar; 100(3):436-443. PubMed ID: 33010027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borderline ovarian tumors in Finland: epidemiology and familial occurrence.
    Auranen A; Grénman S; Mäkinen J; Pukkala E; Sankila R; Salmi T
    Am J Epidemiol; 1996 Sep; 144(6):548-53. PubMed ID: 8797514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer.
    Gotlieb WH; Chetrit A; Menczer J; Hirsh-Yechezkel G; Lubin F; Friedman E; Modan B; Ben-Baruch G;
    Gynecol Oncol; 2005 Jun; 97(3):780-3. PubMed ID: 15893369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in incidence of and mortality from uterine and ovarian cancer in Mid and South Limburg, The Netherlands, 1986-2003.
    Kellert IM; Botterweck AA; Huveneers JA; Dirx MJ
    Eur J Cancer Prev; 2009 Feb; 18(1):85-9. PubMed ID: 19077569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ovarian cancer and borderline tumors].
    Bjørge T; Engeland A; Hansen S; Tropé CG
    Tidsskr Nor Laegeforen; 1998 Jun; 118(16):2471-5. PubMed ID: 9667122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
    Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
    Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer incidence (1989-1991) and mortality (1954-1993) in The Netherlands.
    Koper NP; Kiemeney LA; Massuger LF; Thomas CM; Schijf CP; Verbeek AL
    Obstet Gynecol; 1996 Sep; 88(3):387-93. PubMed ID: 8752245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial invasive and borderline ovarian tumors by proband status, age and histology.
    Hemminki K; Granström C
    Int J Cancer; 2003 Jul; 105(5):701-5. PubMed ID: 12740921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
    Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
    Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second neoplasms after invasive and borderline ovarian cancer.
    Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
    Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of ovarian cancer in Sweden, 1960-1984.
    Adami HO; Bergström R; Persson I; Sparén P
    Am J Epidemiol; 1990 Sep; 132(3):446-52. PubMed ID: 2389749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.